You searched for "parents"

3559 results found

Recalcitrant chronic rhinosinusitis: What to do next?

Whilst the majority of patients with chronic rhinosinusitis (CRS) will significantly improve with treatment, we are sometimes left with a ‘hard-core’ of nasal cripples who fail to improve despite our best efforts. How can we deal with these patients? Valerie...

Romet announces new distributor in UK & Ireland. Additional distributors sought globally.

Tommy R. Dodson, President of Fountain Head Marketing dba Romet Electronic Larynx, is pleased to announce that Severn Healthcare Technologies Limited has been selected to become the exclusive authorised distributor of Romet branded electronic larynx devices in the UK & Ireland.

Head and neck cancer awareness

Head and neck cancer is one of the most preventable cancers, and awareness and screening campaigns have shown a decline in its incidence. Support for campaigns of awareness and education about these cancers is crucial from professional, societal and governmental...

Can we prevent chronic rhinosinusitis?

The old adage ‘prevention is better than cure’ is considered by Professor Hopkins in respect to chronic rhinosinusitis, a condition affecting around 10% of the adult population and associated with huge impact on quality of life and economic cost. A...

Septoplasty under local and general anaesthetic

This Turkish prospective, non-randomised study compared the quality of life outcomes in 50 patients who underwent local anaesthetic (LA) septoplasty, and 50 patients who underwent general anaesthetic (GA) septoplasty over a six-month period. Quality of life outcomes were measured using...

Polypharmacy in the vestibular clinic

Polypharmacy is defined as the simultaneous use of five or more medications and its prevalence is increasing. Dizziness or vertigo are common side effects of polypharmacy. Despite advancements in patient data management, there remains limited information on polypharmacy in patients...

Evaluating and Conducting Research in Audiology

As the only textbook available on research methods in audiology, this book seems likely to be rapidly added to reading lists for undergraduate students. The authors draw on their extensive experience to guide readers through every stage of the research...

Preoperative planning of the surgical patient

This article covers the need to effectively optimise patient status preoperatively to help maximise postoperative outcomes. The article is well written and emphasises close liaison with anaesthetic colleagues particularly regarding airway assessment and nausea and vomiting. As is becoming common...

A voice as smooth as silk?

A number of materials currently exist for vocal fold injection medialisation. Popular options include calcium hydroxylapatite (CaHA), hyaluronic acid (HA) and polydimethylsiloxane (PDMS). The authors of this paper state that there is an unmet need for an injectable material that...

Inequitable access to cochlear implantation across the UK

Referral rates and uptake of cochlear implantation in the global adult population are low. Five audiology centres across England and Wales retrospectively explored data over a six-month period in late 2019, post implementation of new National Institute for Health and...

Precision and personalised genomic and epigenomic medicine in audiology/hearing loss

A detailed look at the pathogenesis of acquired hearing loss due to exposure to ototoxicity during pregnancy or shortly after birth. Insights from genomic medicine have shown that, along with environmental factors causing epigenetic alterations, hearing loss may be caused...

Amplifon’s $2 billion move into manufacturing: what it means for audiology

Our audiology editor Yovina Khiroya writes: Amplifon, the world’s largest hearing aid retailer, has announced a reported $2 billion acquisition of GN Hearing, the company behind ReSound, Beltone and Jabra Enhance. While headline-grabbing, the strategic implications are arguably more significant than the deal value itself.